Almac urges all firms to reap innovation rewards
Global personalised medicine company Almac Diagnostics is part of the Almac Group and focuses on the discovery, development and commercialisation of complex diagnostic and companion diagnostic tests.
Almac Diagnostics is at the cutting edge of personalised medicine and partners with a range of global pharmaceutical and biotech companies to develop and commercialise a range of cancer drugs. Recent work has included projects in the areas of breast, lung and prostate cancer.
Dr Leeona Galligan has worked with Almac since 2009 and has recently been appointed vice president of Almac Diagnostics with responsibility for all UK-based operations including commercial biomarker discovery, validation, clinical test delivery, manufacturing and logistics.
She is also a member of the Almac Diagnostic executive team, helping to define and implement global business strategy.
Leeona is delighted that the company is sponsoring the Excellence in Innovation category at this year's Belfast Telegraph Business Awards.
"Innovation is embedded in Almac Diagnostics' DNA and is one of the Almac Group's five core values," she said.
"In order to maintain its competitive edge and guarantee continual success in partnering with key pharmaceutical and biotech companies to develop and commercialise cancer drugs, Almac Diagnostics' employees are truly innovative in approaches provided to our clients on a daily basis."
Examples of this type of innovation can be demonstrated through the expertise that Almac Diagnostics has developed around targeting the exact cells of interest in patient tissue samples, through a combination of molecular techniques and bespoke software applications.
Having also implemented several business improvement processes during her time at Almac Diagnostics, Leeona is keen to highlight the vital importance of innovation in any organisation.
"Innovation is the key to success and it is therefore essential that businesses promote an environment where employees are encouraged to extend the boundaries of knowledge, technology and creativity," she said.
"This not only enables employees to feel empowered but also gives them a sense of true belonging and pride in what has been achieved.
"In order to grow, a business must never be complacent or stand still - you must keep innovating to stay ahead," Leeona added.
The Almac Group was founded by Sir Allen McClay in 1968.
His inspirational entrepreneurial and innovative spirit is the driving force behind the most successful indigenous company Northern Ireland has ever seen.
Now employing almost 5,000 individuals across 11 facilities throughout Europe, the United States and Asia the company continues to grow from strength to strength.
For information on Almac Diagnostics and Almac Group, visit www.almacgroup.com. For award entry details visit www.belfasttelegraph.co.uk/business/news/business-awards. Closing date for entries is Friday, March 17 at noon. The gala awards dinner takes place on May 4 at the Crowne Plaza, Shaw's Bridge, Belfast. A table of 10 costs £1,300 plus VAT while individual places are £140 plus VAT. For details or to book a table, contact Andrea Kennedy at JComms on mail@ jcomms.co.uk or call 028 9076 0066